Guidelines for hypertension by Dr K K Aggarwal

As many as 25 to 30% people with high blood pressure may have resistant hypertension in India said Padamshri & Dr. BC Roy National Awardee, Dr. KK Aggarwal, President Heart Care Foundation of India & National Vice President Elect IMA.
By: HEART CARE FOUNDATION OF INDIA
 
GREATER KAILASH, India - April 18, 2013 - PRLog -- As per the guidelines published by the American Heart Association and published in Hypertension in patients with resistant hypertension, the blood pressure remains above the target level despite taking three medications to lower it. High blood pressure that's under control but requires four or more medications to treat it, is also considered resistant to treatment.

As many as 25 to 30% people with high blood pressure may have resistant hypertension in India said Padamshri & Dr. BC Roy National Awardee, Dr. KK Aggarwal, President Heart Care Foundation of India & National Vice President Elect IMA.

Older age and obesity are two major risk factors for the condition. People with resistant hypertension have a high cardiovascular risk.

Successful treatment of resistant hypertension requires consideration of lifestyle factors, diagnosing and treating secondary causes, and using multiple drug treatments effectively.

Lifestyle factors include weight, salt intake and alcohol consumption.

1.      Losing weight can lower blood pressure and reduce the number of medications needed to control blood pressure.

2.      Reducing salt intake can lower blood pressure.

3.      Reducing alcohol consumption can help lower blood pressure.

Health conditions that can contribute to resistant hypertension include: obstructive sleep apnea, renal parenchymal disease, primary aldosteronism and renal artery stenosis. Treating these conditions may improve blood pressure control.

Drugs that increase blood pressure, such as non-steroidal anti-inflammatory drugs (NSAIDs), should be reduced or halted, if possible, in patients with resistant hypertension.

Diuretics are often underused in people with resistant hypertension. Patients may benefit from adding mineralocorticoid receptor antagonists (MRAs) to their treatment regimens. MRAs treat primary aldosteronism, which is found in about 20 percent of people with resistant hypertension.

About the author: Padmashri & Dr. B.C. Roy National Awardee, Dr. KK Aggarwal is a Senior Consultant, Physician, Cardiologist at Delhi based Moolchand Medcity; President Heart Care Foundation of India Chairman Ethical Committee Delhi Medical Council and Has served as the Research and Academic Wing Heads of National Indian Medical Association.
End
Source:HEART CARE FOUNDATION OF INDIA
Email:***@gmail.com
Tags:Hypertension, Guidelines, Patients, Cardiovascular, Drug
Industry:Health
Location:Greater Kailash - Delhi - India
? PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share